Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NIH × valdecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Radiotherapy 16 Magnetic Resonance Spectroscopy 16 Psychiatric Rehabilitation 11 Early Intervention, Educational 11 Cyclophosphamide 10 Counseling 9 Biopsy 9 Methotrexate 8 Vincristine 7 Cytarabine 7 Specimen Handling 6 Immunohistochemistry 6 Gene Expression Profiling 6 Doxorubicin 6 Dexamethasone 6 Chemotherapy, Adjuvant 6 Carboplatin 6 Prednisolone 5 Neoadjuvant Therapy 5 Leucovorin 5 Immunoenzyme Techniques 5 High-Energy Shock Waves 5 Colposcopy 5 X-Rays 4 Polymerase Chain Reaction 4 Peripheral Blood Stem Cell Transplantation 4 Human Papillomavirus DNA Tests 4 Fluorouracil 4 Etoposide 4 Cisplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00021996 2013-07-18

Valdecoxib in Treating Chronic Pain in Cancer Patients

National Cancer Institute (NCI)

Phase NA Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡